Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Modified Release Metaxalone 640 mg in Acute Lumbosacral Musculoskeletal Conditions With Spinal Stenosis and Sciatica

NCT06157177 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.

NCT NCT06157177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06157177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Modified Release Metaxalone 640 mg in Acute Lumbosacral Musculoskeletal Conditions With Spinal Stenosis and Sciatica
Lead sponsor
Primus Pharmaceuticals
Phase
Phase 4
Overall status
Recruiting
Start date
November 15, 2023
Completion date
November 15, 2026
Enrollment
50 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar spinal stenosis, sciatica acute